At a glance
ClinicalIndex Comparison RecordN/ACompleted· 266 enrolled
Drug / intervention
Actis Total Hip Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Actis Total Hip System 2 Year Follow-up
In Brief
A clinical study evaluating Actis Total Hip System for Osteoarthritis and 8 related conditions. Completed, enrolled 266 participants across 9 sites.
Detailed Summary
Two-year (2 year) information regarding the performance of the commercially available Actis™ Total Hip System in order to obtain and evaluate the clinical outcomes on a series of cementless primary total hip arthroplasty (THA) and hemi-hip arthroplasty procedures using clinical, radiographic and device and procedure related adverse event assessments.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Traumatic Arthritis, Rheumatoid Arthritis, Congenital Hip Dysplasia, Avascular Necrosis of the Femoral Head, Acute Traumatic Fracture of the Femoral Head or Neck, Certain Cases of Ankylosis, Non-union of Femoral Neck Fractures, Certain High Sub-Capital & Femoral Neck Fractures in Elderly
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 2016
Enrollment StartJul 2016
Primary CompletionMar 2024
TodayJul 2026
First PostedMay 26, 2016
Enrollment StartJul 1, 2016
Primary CompletionMar 13, 2024
TodayJul 2, 2026
Enrollment to primary: 7.7 yearsPosted 10.1 years ago
Interventions
Actis Total Hip Systemdevice
Total Hip Replacement and Hemi-hip Replacement